CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19
22 December 2021 - 1:28AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2024 to May 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From May 2023 to May 2024